Get the App
A

Akero Therapeutics (AKRO)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Akero Therapeutics (AKRO)

Akero Therapeutics Inc. is a cardio-metabolic non-alcoholic steatohepatitis (NASH) company. The Company is focused on developing medicines designed to restore metabolic balance and improve the overall health of patients with NASH. Its lead product ca... Read more

  • USD49.08
  • USD49.08
  • USD46.49
  • USD54.88
  • -2.50%
  • --
  • 165.00
  • 656.03k
  • 2.2B
  • 7.52
  • 161.00%

Stock News

Bond Report: Bond yields rise ahead of release of the Fed’s preferred inflation measure

36 minutes ago

Bond Report: Bond yields rise ahead of release of the Fed’s preferred inflation measure

MarketWatch

Mark Hulbert: This little-known indicator is bullish for 2023

59 minutes ago

Mark Hulbert: This little-known indicator is bullish for 2023

MarketWatch

Robert Powell's Retirement Portfolio: Who gives the best retirement advice? Popular authors or economists?

1 hour ago

Robert Powell's Retirement Portfolio: Who gives the best retirement advice? Popular authors or economists?

MarketWatch

: No, Yellen doesn’t have a side gig as a cabbie. Here’s why the Treasury secretary was behind the wheel.

1 hour ago

: No, Yellen doesn’t have a side gig as a cabbie. Here’s why the Treasury secretary was behind the wheel.

MarketWatch

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.

Try Premium